Mechanistically, G-LNP@S-D not only restores the phagocytic capacity of CD169<sup>+</sup> macrophages to eliminate tumor cells but also activates the STING pathway to enhance antigen presentation and subsequent T cell priming. Here, SIGLEC1 is linked to neoplasm.